In short
This article explores a clinical trial investigating the use of oxogluric acid (also known as alpha-ketoglutarate) and other nutritional supplements in treating propionic acidemia. The study aims to determine if these supplements can improve hyperammonemia, glutamine levels, and overall outcomes in patients with this rare metabolic disorder.
At a glance
- Study Title
- Anaplerotic Therapy in Propionic Acidemia
- Primary Objective
- To determine if nutritional supplements can improve hyperammonemia and outcomes in propionic acidemia patients
- Supplements Tested
- Ornithine alpha-ketoglutarate, Glutamine, Disodium citrate
- Dosage
- 400 mg/kg up to 16 g per day, split into 2 doses
- Trial Duration
- 4 weeks for each supplement, followed by washout periods; best supplement tested for additional 30 weeks
- Expected Outcomes
- Improved plasma glutamine levels, fewer episodes of hyperammonemia, better developmental outcomes
- Potential Impact
- New approach to treating severe metabolic disorders by replacing downstream products involved in energy generation
What is OXOGLURIC ACID?
OXOGLURIC ACID, also known as ornithine alpha-ketoglutarate (OKG), is a nutritional supplement that is being studied as a potential treatment for a rare genetic disorder called propionic acidemia. It's important to note that this substance is not yet approved as a medication for this condition, but is undergoing clinical trials to determine its safety and effectiveness.
Understanding Propionic Acidemia
Propionic acidemia is a rare genetic disorder that affects the body's ability to break down certain proteins and fats. This condition is caused by a deficiency of an enzyme called propionyl CoA carboxylase. As a result, people with this disorder can't properly process some parts of proteins and fats, leading to a build-up of harmful substances in the body.
One of the main problems in propionic acidemia is hyperammonemia, which means there's too much ammonia in the blood. This can be very dangerous and cause serious health problems, including brain damage if not treated promptly.
How OXOGLURIC ACID May Work
Researchers believe that OXOGLURIC ACID might help patients with propionic acidemia by supporting a crucial process in the body called the citric acid cycle (also known as the Krebs cycle). This cycle is essential for producing energy in our cells.
In propionic acidemia, there's a shortage of important substances needed for this cycle to work properly. OXOGLURIC ACID might help by providing some of these missing substances, potentially improving the body's ability to produce energy and handle ammonia better.
Clinical Trial Information
A clinical trial (NCT00645879) is being conducted to study the effects of OXOGLURIC ACID and other similar substances in patients with propionic acidemia. The trial aims to see if these supplements can help reduce hyperammonemia and improve overall health outcomes for patients.
Dosage and Administration
In the clinical trial, OXOGLURIC ACID is being tested at a dose of 400 mg/kg of body weight, up to a maximum of 16 grams per day. This dose is divided into two parts and taken twice a day for 4 weeks. If it's found to be the most effective treatment, it may be continued for an additional 30 weeks.
It's important to note that this dosage is specific to the clinical trial and should not be attempted without medical supervision.
Potential Benefits
The researchers hope that OXOGLURIC ACID might help in several ways: Reducing hyperammonemia (high levels of ammonia in the blood) Improving levels of important amino acids like glutamine and glutamate Enhancing overall energy production in the body Potentially improving developmental outcomes and reducing medical complications
Other Treatments Being Studied
In addition to OXOGLURIC ACID, the clinical trial is also studying two other substances that might help patients with propionic acidemia: Glutamine: This is an amino acid that's important for many bodily functions. It's being tested at the same dose as OXOGLURIC ACID. Disodium citrate (also known as sodium citrate): This is a form of citric acid. It's being tested at a dose of 7.5 mEq/kg or 658 mg/kg, up to a maximum of 16 grams per day.
These substances are all being studied to see which one might be most effective in helping patients with propionic acidemia.